PPR-012 - Testing, prevention, collaboration: A multi-methods study of a Canadian pharmacist-led model for HIV, HCV and syphilis testing (APPROACH 2.0)

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-012
• By: HUGHES, Christine (Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada)
• Co-author(s): Dr Christine Hughes (Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada)
  Mrs Javiera Navarrete (Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada)
  Amanda Butt (School of Pharmacy, Memorial University of Newfoundland & Labrador, St. John's, Canada)
  Ye Zin Zin (School of Pharmacy, Memorial University of Newfoundland & Labrador, St. John's, Canada)
  Zara Matthews (School of Pharmacy, Memorial University of Newfoundland & Labrador, St. John's, Canada)
  Dr Tasha Ramsey (Nova Scotia Health, Halifax, Canada / College of Pharmacy, Dalhousie University, Halifax, Canada)
  Mackenzie d'Entremont-Harris (Nova Scotia Health, Halifax, Canada)
  Shea McInnis (Nova Scotia Health, Halifax, Canada)
  Connor Booker (Nova Scotia Health, Halifax, Canada)
  Dr Kyle Wilby (College of Pharmacy, Dalhousie University, Halifax, Canada)
  Dr Deborah Kelly (School of Pharmacy, Memorial University of Newfoundland & Labrador, St. John's, Canada)
  
• Abstract:

  Background: Rates of sexually transmitted and bloodborne infections (STBBI) are rising globally. The World Health Organization reported 374 million new bacterial cases (chlamydia, gonorrhea, and syphilis) in 2020, and in 2023, around 1.3 million new HIV and 1 million new hepatitis C (HCV) infections occurred. Innovative STBBI testing approaches..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login